To enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DC42069 | RAD16-I hydrochloride |
RAD16-I hydrochloride, a soft nanofibrous self-assembling peptide, is a suitable microenvironment for human mesenchymal stem cells’ (hMSC) proliferation and differentiation into chondrocytes. RAD16-I is a well-studied ionic complementary peptide was used as a model to check potential amyloid-like staining properties of SAPNFs.
More description
|
|
| DC42068 | RAD16-I |
RAD16-I, a soft nanofibrous self-assembling peptide, is a suitable microenvironment for human mesenchymal stem cells’ (hMSC) proliferation and differentiation into chondrocytes. RAD16-I is a well-studied ionic complementary peptide was used as a model to check potential amyloid-like staining properties of SAPNFs.
More description
|
|
| DC42067 | GLP-2(3-33) |
GLP-2(3-33), generated naturally by dipeptidylpeptidase IV (DPPIV), acts as a partial agonist on GLP-2 receptor (EC50=5.8 nM).
More description
|
|
| DC42066 | Human PD-L1 inhibitor III |
Human PD-L1 inhibitor III is a human PD-L1 inhibitor.
More description
|
|
| DC42065 | [Tyr(P)4] Angiotensin II |
[Tyr(P)4] Angiotensin II is a peptide that has multiple effects on vascular smooth muscle, including contraction of normal arteries and hypertrophy or hyperplasia of cultured cells or diseased vessels.
More description
|
|
| DC42064 | β-Amyloid (1-38), mouse, rat |
β-Amyloid (1-38), mouse, rat is composed of 38 aa (1-38 residues of the Aβ peptide) and is the primary component of the amyloid plaques of Alzheimer’s disease.
More description
|
|
| DC42063 | Influenza Matrix Protein (61-72) |
Influenza Matrix Protein (61-72) is a peptide fragment derived from matrix protein of influenza viruses, corresponds to amino acids 61-72. Influenza Matrix Protein (61-72) is a specific epitope which can induce CD4+ T-cell response.
More description
|
|
| DC42062 | LCMV GP (61-80) |
LCMV GP (61-80) is a peptide fragment derived from lymphocytic choriomeningitis virus (LCMV) glycoprotein (GP), and corresponds to amino acids 61-80. LCMV GP (61-80) is a specific epitope which can induce CD4+ T-cell response.
More description
|
|
| DC42061 | CDK7/9 tide |
CDK7/9 tide is peptide substrate for CDK7 or CDK9.
More description
|
|
| DC42060 | GSK3 Substrate, α, β subunit |
GSK3 Substrate, α, β subunit is peptide substrate for glycogen synthase kinase-3 (GSK-3) and can be used to measure GSK-3 activity.
More description
|
|
| DC42059 | Histone H3 (5-23) |
Histone H3 (5-23), derived from histone H3 5-23 amino acids, can be used as a substrate for histone acetyltransferase (HAT) assays.
More description
|
|
| DC42058 | Histone H3 (21-44) |
Histone H3 (21-44), derived from histone H3 21-44 amino acids, is usually used as a substrate (such as protein arginine methyltransferases) for methylation assays.
More description
|
|
| DC42057 | Histone H3 (23-34) |
Histone H3 (23-34) is the histone H3 amino acid residues 23 to 34. Histone H3 (23-34) contains lysine residues at positions 23 and 27 that are subject to methylation and acetylation.
More description
|
|
| DC42056 | Histone H3 (1-25), amide |
Histone H3 (1-25), amide is an N-terminal peptide fragment of histone H3. Histone H3 (1-25), amide can be used to identify the substrate for histone methyltransferases (HMTs). Histone H3 (1-25), amide, as a substrate for HMT G9a, shows more efficient than histone H3 (15-39) and full-length histone H3.
More description
|
|
| DC42055 | Histone H3 (116-136), C116-136 |
Histone H3 (116-136), C116-136 is a peptide spaning the C-terminus of histone H3, amino acids 116 to 136.
More description
|
|
| DC42054 | Histone H3 (1-21) |
Histone H3 (1-21), derived from Histone H3 1-21 amino acids, is usually used as a substrate for methyltransferase (Histone 3 K4 and K9) and acetyltransferase (Histone 3 K9 and K14) assays.
More description
|
|
| DC42053 | Biotin-β-Amyloid (17-40) |
Biotin-β-Amyloid (17-40) is a N-terminal-labelled biotinylated amyloid-?-(1-40) peptide. β-Amyloid (17-40) is a 24-residue fragment of the Aβ protein via?post-translational processing of amyloid precursor protein (APP).
More description
|
|
| DC42052 | β-Amyloid (1-40), FAM-labeled |
β-Amyloid (1-40), FAM-labeled is a FAM fluorescently-labelled?β-Amyloid (1-40) peptide (λex=?492?nm and λem=?518?nm).
More description
|
|
| DC42051 | Biotin-β-Amyloid (1-40) |
Biotin-β-Amyloid (1-40) is a N-terminal-labelled biotinylated amyloid-?-(1-40) peptide.
More description
|
|
| DC42050 | pp60 (v-SRC) Autophosphorylation Site, Phosphorylated |
pp60 (v-SRC) Autophosphorylation Site, Phosphorylated is the phosphorylated peptide of an EGFR substrate. pp60 (v-SRC) Autophosphorylation Site, Phosphorylated can be used for the screening of EGFR Kinase inhibitors via phosphorylated-substrate quantification.
More description
|
|
| DC42049 | Tyrosine Kinase Peptide 1 |
Tyrosine Kinase Peptide 1 is a control substrate peptide for c-Src assay.
More description
|
|
| DC42048 | Biotin-Substance P |
Biotin-Substance P is the biotin tagged Substance P. Substance P (Neurokinin P) is a neuropeptide, acting as a neurotransmitter and as a neuromodulator in the CNS. The endogenous receptor for substance P is neurokinin 1 receptor (NK1-receptor, NK1R).
More description
|
|
| DC42047 | [Tyr1]-Somatostatin-14 |
[Tyr1]-Somatostatin-14 could binds to SSTR2.
More description
|
|
| DC42046 | [Lys8, Lys9]-Neurotensin (8-13) |
[Lys8, Lys9]-Neurotensin (8-13) (JMV438), a Neurotensin analog, exerts its analgesic effects through activation of the G protein-coupled receptors NTS1 and NTS2, with Ki values of 0.33 nM and 0.95 nM for hNTS1 and hNTS2 receptors, respectively.
More description
|
|
| DC42045 | Neuropeptide Y (3-36) (human, rat) |
Neuropeptide Y (3-36) (human, rat), a neuropeptide Y (NPY) metabolite formed from dipeptidyl peptidase-4 (DPP4), is a selective Y2 receptor agonist. Neuropeptide Y (3-36) (human, rat) is a NPY metabolite formed from dipeptidyl peptidase-4 (DPP4). Neuropeptide Y (3-36) (human, rat) decreases release of norepinephrine via the Y2 receptor.
More description
|
|
| DC42044 | GIP (3-42), human |
GIP (3-42), human acts as a glucose-dependent insulinotropic polypeptide (GIP) receptor antagonist, moderating the insulin secreting and metabolic actions of GIP in vivo.
More description
|
|
| DC42043 | GIP (1-30) amide, porcine |
GIP (1-30) amide, porcine is a full glucose-dependent insulinotropic polypeptide (GIP) receptor agonist with high affinity equal to native GIP(1-42).
More description
|
|
| DC42042 | Leptin (93-105), human |
Leptin (93-105), human, is amino acids 93 to 105 fragment of human leptin. Leptin is a 167-residue peptide hormone mainly produced by adipocytes and acts in the central nervous system to primarily coordinate the metabolic adaptations to fasting.
More description
|
|
| DC42041 | Big Endothelin-1 (1-39), porcine |
Big Endothelin-1 (1-39), porcine is the precursor of endothelin-1. Endothelin-1 (ET-1) is a potent vasopressor peptide. Big Endothelin-1 (1-39), porcine has similar pressor effects in vivo.
More description
|
|
| DC42040 | Big Endothelin-1 (1-38), human |
Big Endothelin-1 (1-38), human is the precursor of endothelin-1. Endothelin-1 (ET-1) is a potent vasopressor peptide.
More description
|
|